Gerrit Jan Weverling

Author

Also Known As

G J Weverling, G WEVERLING, G. J. Weverling, G.J Weverling, G.J. Weverling, Gerrit J Weverling, Gerrit J. Weverling, Gerrit Jan Weverling, Gerrit Weverling, Gerrit Jan Weverling

101

Publications

Citations

H-Index

104

Concepts

All Affiliations

University of Amsterdam Amsterdam UMC Location University of Amsterdam Johnson & Johnson (Netherlands)Slotervaartziekenhuis GGD Amsterdam

About

Gerrit Jan Weverling is an author at University of Amsterdam specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	31	2.7K
2	Public Health	5	5	448
3	Health Sciences	1	1	308
4	Allergy	1	1	21
5	Cell Biology	1	1	12

Gerrit Jan Weverling

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination Therapy Ferdinand W N M Wit, Gerrit Jan Weverling, Jan Weel, The Journal of Infectious Diseases	2002	315
Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study Frank de Wolf, Mohsen Ghanbari, Silvan Licher, Brain Geriatric PsychiatryAgingNeurochemical BiomarkersPlasma NflGeriatric Neurology	2020	308
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations Dan H. Barouch, Sandra V. Kik, Gerrit Jan Weverling, Vaccine Diagnostic VirologyViral DiagnosticsInternational SeroepidemiologyVirologyAdenovirus Serotypes 5	2011	302
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets Jan ter Meulen, Alexander B. H. Bakker, Edward N. van den Brink, The Lancet	2004	274
The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4 <sup>+</sup> and CD8 <sup>+</sup> T Cells in Adults Michèle Tameris, Nazma Mansoor, Sebastian Gelderbloem, American Journal of Respiratory and Critical Care Medicine	2010	227
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection Gerrit Jan Weverling, Amanda Mocroft, Bruno Ledergerber, The Lancet Active Antiretroviral TherapyHiv-1 InfectionHivMedicineAids Pathogenesis	1999	223
Predictive Value of the Pretreatment Extent of Disease System in Hepatoblastoma: Results From the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 Study Daniël C. Aronson, J. Marco Schnater, Chris R. Staalman, Journal of Clinical Oncology	2005	214
Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposiʼs sarcoma Neil Renwick, Teysir Halaby, Gerrit Jan Weverling, AIDS	1998	210
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals Agnes I. Veldkamp, Gerrit Jan Weverling, Joep M. A. Lange, AIDS	2001	207
Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy Norbert A. Foudraine, Gerrit Jan Weverling, Tom van Gool, AIDS	1998	194

Page 1